Ciencias de la Salud
Área
Instituto de Neurociencias del Principado de Asturias
Oviedo, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Neurociencias del Principado de Asturias (19)
2023
2022
-
Activities of Daily Living in Parkinson Disease: Are They Related to Short Term and Working Memory and Visuospatial Abilities?
Topics in Geriatric Rehabilitation, Vol. 38, Núm. 4, pp. 285-295
-
Eating and nutritional habits in patients with schizophrenia
Revista de Psiquiatria y Salud Mental, Vol. 15, Núm. 1, pp. 54-60
2021
-
Evaluation of Visuospatial Short-term and Working Memory from the First to Second Year of Life: A Novel Task
Developmental Neuropsychology, Vol. 46, Núm. 1, pp. 16-32
2020
-
COVID-19 lockdown in people with severe mental disorders in Spain: Do they have a specific psychological reaction compared with other mental disorders and healthy controls?
Schizophrenia Research, Vol. 223, pp. 192-198
-
Cognitive impairment and C-reactive protein in clinically stable schizophrenia outpatients: a focus on sex differences
Scientific Reports, Vol. 10, Núm. 1
-
Early psychological impact of the 2019 coronavirus disease (COVID-19) pandemic and lockdown in a large Spanish sample
Journal of global health, Vol. 10, Núm. 2, pp. 020505
-
Patients with Parkinson's Disease Show Alteration in their Visuospatial Abilities and in their Egocentric and Allocentric Spatial Orientation Measured by Card Placing Tests
Journal of Parkinson's Disease, Vol. 10, Núm. 4, pp. 1807-1816
-
Performance on Daily Life Activities and Executive Functioning in Parkinson Disease
Topics in Geriatric Rehabilitation, Vol. 36, Núm. 4, pp. 252-259
-
Prevalence of Passive Suicidal Ideation in the Early Stage of the Coronavirus Disease 2019 (COVID-19) Pandemic and Lockdown in a Large Spanish Sample
The Journal of clinical psychiatry, Vol. 81, Núm. 6
-
Smoking cessation improves clinical outcome in severe mental disorders and is modulated by genetic variability at CHRNA5 gene
Schizophrenia Research
2019
-
Can interleukin-2 and interleukin-1β be specific biomarkers of negative symptoms in schizophrenia?
Revista de Psiquiatria y Salud Mental, Vol. 12, Núm. 1, pp. 9-16
-
Early versus late stage schizophrenia. What markers make the difference?
World Journal of Biological Psychiatry, Vol. 20, Núm. 2, pp. 159-165
-
History of Lifetime Cannabis Use Is Associated with Better Cognition and Worse Real-World Functioning in Schizophrenia Spectrum Disorders
European Addiction Research, Vol. 25, Núm. 3, pp. 111-118
-
Predicting real-world functioning in outpatients with schizophrenia: Role of inflammation and psychopathology
Psychiatry Research, Vol. 280
-
Spatial memory in young adults: Gender differences in egocentric and allocentric performance
Behavioural Brain Research, Vol. 359, pp. 694-700
2018
-
Elevated C-reactive protein as a predictor of a random one-year clinical course in the first ten years of schizophrenia
Psychiatry Research, Vol. 269, pp. 688-691
-
Regulation of inflammatory pathways in schizophrenia: A comparative study with bipolar disorder and healthy controls
European Psychiatry, Vol. 47, pp. 50-59
2016
-
Biomarcadores sanguíneos diferenciales de las dimensiones psicopatológicas de la esquizofrenia
Revista de Psiquiatria y Salud Mental